Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 3, 2010, Pages 1016-1021

  Brown, Elizabeth M ^a,b   Fisman, David N ^a,b   Drews, Steven J ^c   Dolman, Sharon ^d   Rawte, Prasad ^a   Brown, Shirley ^a   Jamieson, Frances ^a,b  

^a PUBLIC HEALTH ONTARIO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PROVINCIAL LABORATORY FOR PUBLIC HEALTH   (Canada)

^d ONTARIO MINISTRY OF HEALTH AND LONG TERM CARE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CHLORAMPHENICOL; PENICILLIN G; RIFAMPICIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BLOOD GROUP TYPING; CANADA; DRUG SENSITIVITY; HUMAN; INCIDENCE; INFECTION RISK; INVASIVE MENINGOCOCCAL DISEASE; MENINGOCOCCOSIS; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NEISSERIA MENINGITIDIS; PHENOTYPE; POISSON DISTRIBUTION; PREDICTOR VARIABLE; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ADOLESCENT; AGED; ANTI-BACTERIAL AGENTS; CHILD, PRESCHOOL; HUMANS; INCIDENCE; INFANT; MENINGOCOCCAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; NEISSERIA MENINGITIDIS; ONTARIO; PENICILLIN RESISTANCE; PENICILLINS; YOUNG ADULT;

EID: 77149165391     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01077-09     Document Type: Article

References (38)

1. Abdillahi, H., and J. T. Poolman. 1987. Whole-cell ELISA for typing of Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol. Lett. 48:367-371.
2. Reference deleted.
3. Antignac, A., M. Ducos-Galand, A. Guiyoule, R. Pirès, J. Alonso, and M. Taha. 2003. Neisseria meningitidis strains isolated from invasive infections in France (1999-2002): phenotypes and antibiotic susceptibility patterns. Clin. Infect. Dis. 37:912-920.
4. Association of Public Health Epidemiologists of Ontario. 24 June 2008, accession date. Geography in Ontario. Association of Public Health Epidemiologists of Ontario, Ottawa, Canada. http://www.apheo.ca/index.php?pid =195.
5. Balmer, P., R. Burrow, and E. Miller. 2002. Impact of meningococcal C conjugate vaccine in the UK. J. Med. Microbiol. 51:717-722.
6. Botha, P. 1988. Penicillin-resistant Neisseria meningitidis in southern Africa. Lancet i:54.
7. Brown, S., G. Riley, and F. Jamieson. 2001. Neisseria meningitidis with decreased susceptibility to penicillin in Ontario, Canada 1997-2000. Can. Commun. Dis. Rep. 27:73-75.
8. Canica, M., R. Dias, B. Nunes, L. Carvalho, and E. Ferreira. 2004. Invasive culture-confirmed Neisseria meningitidis in Portugal: evaluation of serogroups in relation to different variables and antimicrobial susceptibility (2000-2001). J. Med. Microbiol. 53:921-925.
9. Centers for Disease Control and Prevention. 2008. Emergence of fluoroquinolone-resistant Neisseria meningitidis-Minnesota and North Dakota, 2007-2008. MMWR Morb. Mortal. Wkly. Rep. 57:173-175.
10. Clinical and Laboratory Standards Institute. 2005. Performance standards for antimicrobial susceptibility testing. Fifteenth informational supplement. M100-S15, p.138-139. Clinical and Laboratory Standards Institute, Wayne, PA.
11. Clinical and Laboratory Standards Institute. 2005. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard M7-A7, 6th ed. Clinical and Laboratory Standards Institute, Wayne, PA.
12. Diggle, M. A., and S. C. Clarke. 2005. Increased genetic diversity of Neisseria meningitidis isolates after the introduction of the meningococcal serogroup C polysaccharide conjugate vaccines. J. Clin. Microbiol. 43:4649-4653.
13. Donalisio, M. R., B. Kemp, M. M. Rocha, and R. M. Ramalheira. 2000. Fatality rate in the epidemiology of meningococcal disease: study in the region of the Campinas, SP, Brazil, 1993 to 1998. Rev. Saude Publica 34: 589-595. (In Portuguese.)
14. du Plessis, M., A. von Gottberg, C. Cohen, L. de Gouveia, and K. P. Klugman. 2008. Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005. J. Clin. Microbiol. 46:3208-3214.
15. García-Rey, C., L. Aguilar, F. Baquero, J. Casal, and R. Dal-Ré. 2002. Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. J. Clin. Microbiol. 40:159-164.
16. Jensen, E. S., H. C. Schønheyder, I. Lind, L. Berthelsen, B. Nørgard, and H. T. Sørensen. 2003. Neisseria meningitidis phenotypic markers and septicaemia, disease progress and case-fatality rate of meningococcal disease: a 20-year population based historical follow-up study in a Danish county. J. Med. Microbiol. 52:173-179.
17. Jorgensen, J. H., S. A. Crawford, and K. R. Fiebelkorn. 2005. Susceptibility of Neisseria meningitidis to 16 antimicrobial agents and characterization of resistance mechanisms affecting some agents. J. Clin. Microbiol. 43:3162-3171.
18. Kyaw, M. H., J. C. Bramley, S. Clark, P. Christie, I. G. Jones, and H. Campbell. 2002. Prevalence of moderate penicillin resistant invasive Neisseria meningitidis infection in Scotland, 1994-9. Epidemiol. Infect. 128:149-156.
19. Lopalco, P. L. 2008. Is there room for improving case management for contacts of meningococcal disease in the European Union? Euro Surveill. 13:pii=8057.
20. Luaces Cubells, C., J. J. García García, J. Roca Martinez, and C. L. Latorre Otin. 1997. Clinical data in children with meningococcal meningitis in a Spanish hospital. Acta Pediatr. 86:26-29.
21. Mothershed, E. A., C. T. Sacchi, A. M. Whitney, G. A. Barnett, G. W. Ajello, S. Schmink, L. W. Mayer, M. Phelan, T. H. Taylor, Jr., S. A. Bernhardt, N. E. Rosenstein, and T. Popovic. 2004. Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J. Clin. Microbiol. 42:320-328.
22. National Advisory Committee on Immunization. 2001. Statement on the recommended use of meningococcal vaccines. Can. Commun. Dis. Rep. 27:1-36.
23. Navarro, C., S. L. Deeks, A. Medaglia, and R. S. W. Tsang. 2007. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005. Can. Commun. Dis. Rep. 33:1-15.
24. Public Health Agency of Canada. 2000. Case definitions for diseases under national surveillance. Can. Commun. Dis. Rep. 26(S3):1-73.
25. Public Health Agency of Canada. 2005. Supplement: guidelines for the prevention and control of meningococcal disease. Can. Commun. Dis. Rep. 31(S1):1-20.
26. Public Health Agency of Canada. 10 September 2008, accession date. Publicly funded immunization programs in Canada-routine schedule for infants and children (including special programs and catch-up programs). Public Health Agency of Canada, Ottawa, Canada. http://www.phac-aspc.gc.ca/im/ptimprog- progimpt/table-1-eng.php.
27. Riley, G., S. Brown, and C. Krishnan. 1991. Penicillin resistance in Neisseria meningitidis. N. Engl. J. Med. 324:997.
28. Rosenstein, N. E., B. A. Perkins, D. S. Stephens, T. Popovic, and J. M. Hughes. 2001. Meningococcal disease. N. Engl. J. Med. 344:1378-1388.
29. Sutcliffe, E. M., D. M. Jones, S. el-Sheikh, and A. Percival. 1988. Penicillininsensitive meningococci in the UK. Lancet i:657-658.
30. Tapsall, J. W., T. Shultz, E. Limnios, R. Munro, J. Mercer, R. Porritt, J. Griffith, G. Hogg, G. Lum, A. Lawrence, D. Hansman, P. Collignon, P. Southwell, K. Ott, M. Gardam, K. J. L. Richardson, J. Bates, D. Murphy, and H. Smith. 2001. Surveillance of antibiotic resistance in invasive isolates of Neisseria meningitidis in Australia 1994-1999. Pathology 33:359-361.
31. Trotter, C. L., A. J. Fox, M. E. Ramsay, F. Sadler, S. J. Gray, R. Mallard, and E. B. Kaczmarski. 2002. Fatal outcome from meningococcal disease - an association with meningococcal phenotype but not with reduced susceptibility to benzylpenicillin. J. Med. Microbiol. 51:855-860.
32. Tsang, R. S. W., S. G. Squires, and T. W. S. Tam. 2003. Characterization of Neisseria meningitidis strains isolated from invasive meningococcal disease cases in Canada in 2001. Can. J. Microbiol. 49:633-638.
33. Tsang, R. S. W., S. G. Squires, W. D. Zollinger, and F. E. Ashton. 2002. Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001. Can. J. Infect. Dis. 13:391-396.
34. Turner, P. C., K. W. Southern, N. J. B. Spencer, and H. Pullen. 1990. Treatment failure in meningococcal meningitis. Lancet 335:732-733.
35. Tzanakaki, G., and P. Mastrantonio. 2007. Aetiology of bacterial meningitis and resistance to antibiotics of causative pathogens in Europe and in the Mediterranean region. Int. J. Antimicrob. Agents 29:621-629.
36. Van Esso, D., D. Fontanals, S. Uriz, M. A. Morera, T. Juncosa, C. Latorre, and M. Duran. 1987. Neisseria meningitidis strains with decreased susceptibility to penicillin. Pediatr. Infect. Dis. J. 6:438-439.
37. Vazquez, J. A. 2001. The resistance of Neisseria meningitidis to the antimicrobial agents: an issue still in evolution. Rev. Med. Microbiol. 12:39-45.
38. Wu, H. M., B. H. Harcourt, C. P. Hatcher, S. C. Wei, R. T. Novak, X. Wang, B. A. Juni, A. Glennen, D. J. Boxrud, J. Rainbow, S. Schmink, R. D. Mair, M. J. Theodore, M. A. Sander, T. K. Miller, K. Kruger, A. C. Cohn, T. A. Clark, N. E. Messonnier, L. W. Mayer, and R. Lynfield. 2009. Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. N. Engl. J. Med. 360:886-892.